Literature DB >> 16534868

Prognostic factors in patients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma.

Dong Yi Kim1, Kyeung Won Seo, Jae Kyoon Joo, Young Kyu Park, Seong Yeob Ryu, Hyeong Rok Kim, Young Jin Kim, Shin Kon Kim.   

Abstract

AIM: To identify the clinicopathological characteristics of lymph node-negative gastric carcinoma, and also to evaluate outcome indicators in the lymph node-negative patients.
METHODS: Of 2848 gastric carcinoma patients, 1524 (53.5%) were lymph node-negative. A statistical analysis was performed using the Cox model to estimate outcome indicators.
RESULTS: There was a significant difference in the recurrence rate between lymph node-negative and lymph node-positive patients (14.4% vs 41.0%, P<0.001). The 5-year survival rate was significantly lower in lymph node-positive than in lymph node-negative patients (31.1% vs 77.4%, P<0.001). Univariate analysis revealed that the following factors influenced the 5-year survival rate: patient age, tumor size, depth of invasion, tumor location, operative type, and tumor stage at initial diagnosis. The Cox proportional hazard regression model revealed that tumor size, serosal invasion, and curability were independent, statistically significant, prognostic indicators of lymph node-negative gastric carcinoma.
CONCLUSION: Lymph node-negative patients have a favorable outcome attributable to high curability, but the patients with relatively large tumors and serosal invasion have a poor prognosis. Curability is one of the most reliable predictors of long-term survival for lymph node-negative gastric carcinoma patients.

Entities:  

Mesh:

Year:  2006        PMID: 16534868      PMCID: PMC4124426          DOI: 10.3748/wjg.v12.i8.1182

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

Review 1.  Clinicopathologic studies of gastric carcinoma.

Authors:  M Mori; K Sugimachi
Journal:  Semin Surg Oncol       Date:  1990

2.  Surgical treatment and outcome for node-negative gastric cancer.

Authors:  Y Maehara; M Tomoda; S Tomisaki; M Ohmori; H Baba; K Akazawa; K Sugimachi
Journal:  Surgery       Date:  1997-06       Impact factor: 3.982

3.  Significant prognostic factors in patients with node-negative gastric cancer.

Authors:  T Yokota; Y Kunii; S Teshima; Y Yamada; T Saito; M Takahashi; S Kikuchi; H Yamauchi
Journal:  Int Surg       Date:  1999 Oct-Dec

4.  Clinicopathologic characteristics and outcome indicators in node-negative gastric cancer.

Authors:  L Bruno; G Nesi; F Montinaro; G Carassale; V Boddi; P Bechi; C Cortesini
Journal:  J Surg Oncol       Date:  2000-05       Impact factor: 3.454

5.  A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases.

Authors:  T Mitsudomi; T Matsusaka; K Wakasugi; M Takenaka; K Kume; Y Fujinaga; H Teraoka; A Iwashita
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

6.  Gastric cancer surgery in patients aged at least 80 years old.

Authors:  J Takeda; T Tanaka; K Koufuji; I Kodama; Y Tsuji; T Kakegawa
Journal:  Hepatogastroenterology       Date:  1994-12

7.  Should patients over 80 years old be operated on for colorectal or gastric cancer?

Authors:  S Houry; J Amenabar; A Rezvani; M Huguier
Journal:  Hepatogastroenterology       Date:  1994-12

8.  Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.

Authors:  Y Adachi; T Suematsu; N Shiraishi; H Tanimura; A Morimoto; S Kitano
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

9.  Death due to recurrence following curative resection of early gastric cancer depends on age of the patient.

Authors:  S Moriguchi; T Odaka; Y Hayashi; Y Nose; Y Maehara; D Korenaga; K Sugimachi
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

10.  Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer.

Authors:  L E Harrison; M S Karpeh; M F Brennan
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  20 in total

1.  Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer.

Authors:  In Keun Choi; Hee Yun Seo; Hwa Jung Sung; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Jae Hong Seo; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

2.  Effect of lymphadenectomy extent on advanced gastric cancer located in the cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-14       Impact factor: 5.742

3.  Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus.

Authors:  Chang-Ming Huang; Bi-Juan Lin; Hui-Shan Lu; Xiang-Fu Zhang; Ping Li; Jian-Wei Xie
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

4.  Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.

Authors:  Jingyu Deng; Han Liang; Dan Sun; Rupeng Zhang; Hongjie Zhan; Xiaona Wang
Journal:  Can J Gastroenterol       Date:  2008-10       Impact factor: 3.522

5.  Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.

Authors:  Lei Huang; Odile David; Robert J Cabay; Klara Valyi-Nagy; Virgilia Macias; Rong Zhong; Barry Wenig; Lawrence Feldman; Ralph Weichselbaum; Michael T Spiotto
Journal:  Clin Cancer Res       Date:  2018-12-20       Impact factor: 12.531

6.  Clinicopathological and prognostic differences between mucinous gastric carcinoma and signet-ring cell carcinoma.

Authors:  Zhaode Bu; Zhixue Zheng; Ziyu Li; Xiaojiang Wu; Lianhai Zhang; Aiwen Wu; Xianglong Zong; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

7.  Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience.

Authors:  Yves Dittmar; Silke Schüle; Alexander Koch; Falk Rauchfuss; Hubert Scheuerlein; Utz Settmacher
Journal:  Langenbecks Arch Surg       Date:  2014-07-23       Impact factor: 3.445

8.  A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma.

Authors:  Wenguang Luo; Hongyan Zhang; Yufei Zhao; Lin Wang; Lijun Qi; Jingjing Ran; Lei Liu; Aidong Wu
Journal:  Mol Clin Oncol       Date:  2016-03-07

Review 9.  Clinical significance of lymph node metastasis in gastric cancer.

Authors:  Jing-Yu Deng; Han Liang
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  Effect of lymph node micrometastases on prognosis of gastric carcinoma.

Authors:  Ze-Yu Wu; Jing-Hua Li; Wen-Hua Zhan; Yu-Long He; Jin Wan
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.